Markov AV

ORCID: 0000-0001-7569-9555 · 1 paper in corpus

2025

Transcriptomic-Driven Drug Repurposing Reveals SP600125 as a Promising Drug Candidate for the Treatment of Glial-Mesenchymal Transition in Glioblastoma.

International journal of molecular sciences ·doi:10.3390/ijms26199772

Glioblastoma multiforme (GBM) is an aggressive brain cancer characterized by highly invasive growth driven by glial-mesenchymal transition (GMT). Given the urgent need for effective therapies targeting this process, we aimed to discover pot…